H.C. Wainwright Sticks to Their Buy Rating for Cabaletta Bio (CABA)
November 11 2022 - 06:26AM
TipRanks
In a report released today, Douglas Tsao from H.C. Wainwright
reiterated a Buy rating on Cabaletta Bio (CABA - Research Report),
with a price target of $11.00. The company's shares closed
yesterday at $2.03.According to TipRanks, Tsao is a 3-star analyst
with an average return of 1.4% and a 38.44% success rate. Tsao
covers the Healthcare sector, focusing on stocks such as Cabaletta
Bio, Revance Therapeutics, and Daré Bioscience.Cabaletta Bio has an
analyst consensus of Strong Buy, with a price target consensus of
$8.20, implying a 303.94% upside from current levels. In a report
released yesterday, Mizuho Securities also maintained a Buy rating
on the stock with a $10.
https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-cabaletta-bio-caba?utm_source=advfn.com&utm_medium=referral
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From May 2023 to Jun 2023
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Jun 2022 to Jun 2023